Parallel Advisors LLC Grows Stock Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

Parallel Advisors LLC grew its holdings in Shockwave Medical, Inc. (NASDAQ:SWAVFree Report) by 3.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,268 shares of the company’s stock after buying an additional 47 shares during the period. Parallel Advisors LLC’s holdings in Shockwave Medical were worth $242,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in SWAV. Asset Management One Co. Ltd. bought a new stake in Shockwave Medical during the fourth quarter worth approximately $34,000. Quest Partners LLC bought a new position in Shockwave Medical during the 4th quarter valued at about $41,000. Operose Advisors LLC purchased a new stake in Shockwave Medical in the 3rd quarter worth about $49,000. Covestor Ltd lifted its stake in Shockwave Medical by 484.9% in the third quarter. Covestor Ltd now owns 427 shares of the company’s stock worth $85,000 after purchasing an additional 354 shares during the last quarter. Finally, Principal Securities Inc. bought a new stake in Shockwave Medical in the fourth quarter worth about $106,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

SWAV has been the topic of several recent analyst reports. CL King reiterated a “neutral” rating on shares of Shockwave Medical in a report on Monday, April 8th. TheStreet upgraded Shockwave Medical from a “c+” rating to a “b” rating in a research note on Thursday, February 15th. Piper Sandler boosted their target price on shares of Shockwave Medical from $290.00 to $360.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $335.00 price target (up previously from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Wells Fargo & Company boosted their price objective on shares of Shockwave Medical from $200.00 to $210.00 and gave the company an “equal weight” rating in a research report on Friday, February 16th. Ten equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $309.11.

Get Our Latest Report on SWAV

Shockwave Medical Trading Down 0.0 %

Shares of NASDAQ:SWAV opened at $334.75 on Monday. The company has a current ratio of 13.81, a quick ratio of 12.61 and a debt-to-equity ratio of 0.97. The company has a market capitalization of $12.57 billion, a PE ratio of 78.21, a P/E/G ratio of 2.43 and a beta of 0.88. Shockwave Medical, Inc. has a 12-month low of $157.00 and a 12-month high of $334.90. The business’s fifty day simple moving average is $327.94 and its 200-day simple moving average is $257.55.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last announced its earnings results on Monday, May 6th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. The business had revenue of $218.80 million during the quarter, compared to the consensus estimate of $207.69 million. Shockwave Medical had a net margin of 20.75% and a return on equity of 24.79%. The firm’s revenue was up 35.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.03 earnings per share. As a group, equities research analysts predict that Shockwave Medical, Inc. will post 5.05 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total value of $1,150,680.00. Following the transaction, the insider now directly owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Isaac Zacharias sold 4,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the sale, the insider now owns 56,818 shares in the company, valued at approximately $16,344,834.06. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Frank T. Watkins sold 2,000 shares of the business’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $253.65, for a total value of $507,300.00. Following the transaction, the director now owns 4,532 shares in the company, valued at $1,149,541.80. The disclosure for this sale can be found here. Insiders sold a total of 7,521 shares of company stock worth $2,113,296 in the last 90 days. 3.40% of the stock is owned by corporate insiders.

Shockwave Medical Profile

(Free Report)

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Read More

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAVFree Report).

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.